Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

导出 OA

翻译打印收藏纠错

第一作者： Matthew J,Maurer

第一单位： Matthew J. Maurer, Thomas M. Habermann, Carrie A. Thompson, Cristine Allmer, Patrick B. Johnston, Ivana N. Micallef, David J. Inwards, William R. Macon, Andrew L. Feldman, Susan L. Slager, Stephen M. Ansell, James R. Cerhan, Thomas E. Witzig, and Grzegorz S. Nowakowski, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Gilles A. Salles, Université Claude Bernard, Lyon; Jean-Philippe Jais, Richard Delarue, Thierry J. Molina, Hopital Necker, Paris; Corinne Haioun, Groupe Hospitalier Mondor, Créteil; Frederic Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux; Hervé Tilly, Centre de lutte Contre le Cancer Henri Becquerel, Rouen, France; Brian K. Link, Umar Farooq, Sergei Syrbu, and George J. Weiner, University of Iowa, Iowa City, IA; and Nicolas Ketterer, Clinique Bois-Cerf, Lausanne, Switzerland.

作者： Matthew J,Maurer ^[1] ; Hervé,Ghesquières ^[1] ; Brian K,Link ^[1] ; Jean-Philippe,Jais ^[1] ; Thomas M,Habermann ^[1] ; Carrie A,Thompson ^[1] ; Corinne,Haioun ^[1] ; Cristine,Allmer ^[1] ; Patrick B,Johnston ^[1] ; Richard,Delarue ^[1] ; Ivana N,Micallef ^[1] ; Frederic,Peyrade ^[1] ; David J,Inwards ^[1] ; Nicolas,Ketterer ^[1] ; Umar,Farooq ^[1] ; Olivier,Fitoussi ^[1] ; William R,Macon ^[1] ; Thierry J,Molina ^[1] ; Sergei,Syrbu ^[1] ; Andrew L,Feldman ^[1] ; Susan L,Slager ^[1] ; George J,Weiner ^[1] ; Stephen M,Ansell ^[1] ; James R,Cerhan ^[1] ; Gilles A,Salles ^[1] ; Thomas E,Witzig ^[1] ; Hervé,Tilly ^[1] ; Grzegorz S,Nowakowski ^[1]

作者单位： Matthew J. Maurer, Thomas M. Habermann, Carrie A. Thompson, Cristine Allmer, Patrick B. Johnston, Ivana N. Micallef, David J. Inwards, William R. Macon, Andrew L. Feldman, Susan L. Slager, Stephen M. Ansell, James R. Cerhan, Thomas E. Witzig, and Grzegorz S. Nowakowski, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Gilles A. Salles, Université Claude Bernard, Lyon; Jean-Philippe Jais, Richard Delarue, Thierry J. Molina, Hopital Necker, Paris; Corinne Haioun, Groupe Hospitalier Mondor, Créteil; Frederic Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux; Hervé Tilly, Centre de lutte Contre le Cancer Henri Becquerel, Rouen, France; Brian K. Link, Umar Farooq, Sergei Syrbu, and George J. Weiner, University of Iowa, Iowa City, IA; and Nicolas Ketterer, Clinique Bois-Cerf, Lausanne, Switzerland. ^[1]